FlocaRx

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	12-06-2026	49 d early	2026-00155438
31-12-2024	31-07-2025	12-06-2025	49 d early	2025-00138743
31-12-2023	31-07-2024	11-06-2024	50 d early	2024-00125542
31-12-2022	31-07-2023	15-06-2023	46 d early	2023-00127912
31-12-2021	31-07-2022	14-07-2022	17 d early	2022-20188916

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€690k
Fixed assets	21/28	€287k
Intangible fixed assets	21	€282k
Tangible fixed assets	22/27	€4k
Financial fixed assets	28	€75
Current assets	29/58	€404k
Amounts receivable within one year	40/41	€3k
Cash & bank	54/58	€401k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€690k
Equity	10/15	€392k
Contributions / capital	10/11	€3k
Accumulated profits (losses)	14	€389k
Amounts payable	17/49	€299k
Amounts payable after one year	17	€240k
Amounts payable within one year	42/48	€59k
Trade debts payable within one year	44	€3k
Income statement
Gross operating margin	9900	€569k
Operating result	9901	€516k
Financial charges	65	€3k
Result before taxes	9903	€513k
Income taxes	67/77	€124k
Net result for the period	9904	€389k
Result to be appropriated	9905	€389k

Summary